FRPT Freshpet, Inc.
Grain Mill Products · Nasdaq · SEC CIK 1611647 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.7%
TTM net income YoY6.5%
TTM EPS YoY6.8%
Revenue 3-yr CAGR18.9%
Net income 3-yr CAGR—
Margins
Gross margin42.6%
Operating margin8.8%
Net margin10.9%
FCF margin5.6%
EBITDA margin16.4%
Returns
ROE10.9%
ROA7.4%
ROIC (approx.)9.2%
Asset turnover0.68x
Leverage & solvency
Liabilities / assets32.1%
Debt / equity0.00x
Current ratio5.68x
Interest coverage7.63x
Cash quality & payout
Operating cash flow / net income1.53x
Accruals ratio-3.9%
Payout ratio—
Capex / revenue11.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.10B | $975.18M |
| Cost of revenue | $652.39M | $579.22M |
| Gross profit | $449.63M | $395.96M |
| SG&A expense | $373.95M | $357.96M |
| Operating income | $75.67M | $38.00M |
| Interest expense | $14.12M | $12.26M |
| Pretax income | $70.77M | $47.52M |
| Income tax | -$68.36M | $598,000 |
| Net income | $139.14M | $46.92M |
| EBITDA | $162.07M | $107.50M |
| EPS (basic) | 2.85 | 0.97 |
| EPS (diluted) | 2.64 | 0.93 |
| Weighted avg. shares (diluted) | 56.04M | 50.26M |
| Balance sheet | ||
| Cash & equivalents | $277.98M | $268.63M |
| Short-term investments | — | $0 |
| Receivables | $63.76M | $68.42M |
| Inventory | $76.77M | $80.79M |
| Current assets | $435.71M | $437.00M |
| PP&E, net | $1.14B | $1.07B |
| Total assets | $1.78B | $1.57B |
| Current liabilities | $78.59M | $98.87M |
| Total liabilities | $569.12M | $519.52M |
| Shareholders' equity | $1.21B | $1.06B |
| Shares outstanding | 48.97M | 48.70M |
| Cash flow statement | ||
| Operating cash flow | $160.56M | $154.29M |
| Capital expenditure | $148.18M | $187.09M |
| Free cash flow | $12.38M | -$32.80M |
| Investing cash flow | -$148.18M | -$187.09M |
| Financing cash flow | -$3.04M | $4.57M |
| Depreciation & amortization | $86.40M | $69.50M |
| Stock-based compensation | $13.88M | $51.81M |
Free plan shows the latest 2 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.